News

Circadian rhythms in mammals rely on cell-autonomous molecular clocks that operate in many tissues and organs. New research in The EMBO Journal quantifies the expression dynamics, distribution, ...
Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...
Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...
The rising global demand for high-quality aquatic protein has fueled the growth of the aquaculture industry. Despite this, ...
Doudna's insights on the future of CRISPR in medicine and agriculture, including the barriers that must be overcome to pave ...
In a quiet lab in Bayreuth, Germany, a team of researchers has achieved what has long eluded geneticists: modifying the ...
In the assessment of 12-month price targets, analysts unveil insights for Intellia Therapeutics, presenting an average target ...